Insulet PODD
NASDAQ PODD
$149.19 -2.32 (-1.53%)
At close: Aug 20, 2026 · 1:13 PM UTC

Insulet (PODD) Liabilities and Shareholders Equity (2010 - 2026)

Insulet's (PODD) quarterly Liabilities and Shareholders Equity came in at $3.0 billion in Q1 2026, down 15.07% YoY from $3.5 billion in Q1 2025, and down 6.37% on a QoQ basis from $3.2 billion in Q4 2025.

Insulet (PODD) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Insulet (PODD) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $3.0 billion in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity fell 15.07% year-over-year to $3.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.7 billion (up 1.31% YoY) and the FY2025 annual result came in at $3.2 billion, up 3.33% from the prior year.
  • Liabilities and Shareholders Equity retreated to $3.0 billion in Q1 2026, from $3.2 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $3.5 billion in Q1 2025 to a low of $2.1 billion in Q1 2022.
  • A 5-year average of $2.7 billion and a median of $2.6 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2025 — Liabilities and Shareholders Equity soared 34.04% — and 2026, when it declined 15.07%.
  • Tracing PODD's Liabilities and Shareholders Equity over 5 years: stood at $2.3 billion in 2022, then climbed by 14.97% to $2.6 billion in 2023, then grew by 19.3% to $3.1 billion in 2024, then advanced by 3.33% to $3.2 billion in 2025, then fell by 6.37% to $3.0 billion in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $3.0 billion (Q1 2026), $3.2 billion (Q4 2025), and $3.0 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 199.24 Bn 193.64 Bn 7.27 Bn 109.22 Bn
2 Stryker 128.63 Bn 125.15 Bn 4.50 Bn 47.93 Bn
3 Medtronic 119.19 Bn 109.97 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 73.51 Bn 72.97 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 52.11 Bn 47.85 Bn 1.35 Bn 13.87 Bn
6 Dexcom 34.64 Bn 32.70 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 34.01 Bn 31.90 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.40 Bn 23.08 Bn 4.55 Bn 31.04 Bn
9 Steris 23.14 Bn 22.65 Bn 684.20 Mn 10.74 Bn
10 Insulet 10.35 Bn 9.82 Bn 562.60 Mn 3.17 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 3.17 Bn
Mar 31, 2026 2.99 Bn
Dec 31, 2025 3.19 Bn
Sep 30, 2025 3.03 Bn
Jun 30, 2025 3.47 Bn
Mar 31, 2025 3.52 Bn
Dec 31, 2024 3.09 Bn
Sep 30, 2024 3.03 Bn
Jun 30, 2024 2.88 Bn
Mar 31, 2024 2.62 Bn
Dec 31, 2023 2.59 Bn
Sep 30, 2023 2.47 Bn
Jun 30, 2023 2.39 Bn
Mar 31, 2023 2.29 Bn
Dec 31, 2022 2.25 Bn
Sep 30, 2022 2.17 Bn
Jun 30, 2022 2.11 Bn
Mar 31, 2022 2.07 Bn
Dec 31, 2021 2.05 Bn
Sep 30, 2021 2.00 Bn